Journal of Neuroinflammation, August 24, 2026
- Background & Research Objectives
- Background: Chronic Obstructive Pulmonary Disease (COPD) is frequently accompanied by neurocognitive disorders (COPD-NCDs), which severely impair patient quality of life. Persistent neuroinflammation has been identified as a core pathogenesis mechanism.
- Challenge: Effective therapeutic strategies for COPD-induced cognitive impairment remain currently unavailable.
- Objective: To evaluate the potential clinical efficacy and underlying molecular mechanisms of human umbilical cord-derived mesenchymal stem cell exosomes (hUCMSC-Exos) in attenuating neuroinflammation and improving cognitive function in a mouse model of COPD-NCDs.
- Experimental Design & Methodology
- Animal Model: Female BALB/c mice were divided into 4 groups: Normal Control (NC), COPD-NCDs Model, Vehicle Control (COPD-NCDs + PBS), and Treatment Group (COPD-NCDs + Exos).
- Induction & Treatment: Lung and brain injuries were induced by exposing mice to cigarette smoke (CS) continuously for 24 weeks. The treatment group received tail-vein injections of hUCMSC-Exos during weeks 20 to 23.
- Evaluation Parameters & Techniques:
- Respiratory Function: Measurement of lung volume parameters and airway resistance (RI, Cdyn, FEV0.1/FVC, MV, PEF).
- Behavior & Cognition: Assessment via Morris Water Maze (MWM), Novel Object Recognition (NOR), and Open Field Test (OFT).
- Histology: H&E staining, Nissl staining, and immunofluorescence (IF) staining of lung and hippocampal tissues.
- Molecular Mechanisms: Measurement of inflammatory cytokines via ELISA, brain tissue RNA-sequencing (RNA-seq), and biological pathway analysis (KEGG/GO).
- Detailed Results
- Pulmonary Function & Systemic Inflammation: hUCMSC-Exos significantly ameliorated alveolar structural damage, reduced emphysema, decreased lung tissue collagen deposition, and lowered systemic inflammation in COPD mice.
- Neuroprotection & Cognitive Recovery:
- Mice in the treatment group showed marked improvements in spatial memory and orientation performance during MWM and NOR tests.
- Reduced hippocampal neuronal degeneration: Increased density of surviving neurons (Nissl-positive cells) and restored expression of the neuronal marker NeuN.
- Inhibition of Neuroinflammation & Astrocyte Phenotypic Switching:
- Suppressed aberrant activation of microglia (brain immune cells) and reduced pro-inflammatory cytokine secretion.
- Decreased expression of C3 (a marker for neurotoxic A1 astrocytes).
- Increased expression of S100A10 (a marker for neuroprotective A2 astrocytes).
- Molecular Signaling Pathways: RNA-seq analysis confirmed that hUCMSC-Exos directly act on and regulate the MAPK, Wnt, cAMP, and PI3K-Akt signaling pathways.
References
Xiao, H., Yu, X., Dong, Y. et al. Human umbilical cord mesenchymal stem cell-derived exosomes alleviate neurocognitive disorders in chronic obstructive pulmonary disease by suppressing neuroinflammation. J Neuroinflammation (2026). https://doi.org/10.1186/s12974-026-04021-9
Source: Journal of Neuroinflammation
Link: https://link.springer.com/article/10.1186/s12974-026-04021-9#citeas
